Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

NCT00461292 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00461292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00461292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2007
Completion date
April 30, 2010
Enrollment
275 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder